The pharmaceutical company Novartis has presented long-term data on the drug Cosentyx (secukinumab) in use against the skin disease hidradenitis suppurativa (HS).
ttn-28
The pharmaceutical company Novartis has presented long-term data on the drug Cosentyx (secukinumab) in use against the skin disease hidradenitis suppurativa (HS).
ttn-28